{"id":69082,"date":"2026-06-30T11:57:59","date_gmt":"2026-06-30T03:57:59","guid":{"rendered":"https:\/\/flcube.com\/?p=69082"},"modified":"2026-06-30T11:58:00","modified_gmt":"2026-06-30T03:58:00","slug":"roche-launches-axelios-1-next-generation-sequencing-platform-powered-by-proprietary-sbx-technology-single-molecule-system-promises-same-day-whole-genome-results","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=69082","title":{"rendered":"Roche Launches AXELIOS 1 Next-Generation Sequencing Platform Powered by Proprietary SBX Technology \u2013 Single-Molecule System Promises Same-Day Whole Genome Results"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Roche Holding AG<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/ROP:SWX\">SWX: ROP<\/a>; <a href=\"https:\/\/www.google.com\/finance\/quote\/RHHBY:OTCMKTS\">OTCMKTS: RHHBY<\/a>) announced the commercial launch of <strong>AXELIOS 1<\/strong>, its next-generation <strong>single-molecule sequencing platform<\/strong> powered by proprietary <strong>sequencing by expansion (SBX) technology<\/strong>, designed to address critical bottlenecks in genomics research and clinical applications.<\/p>\n\n\n\n<h2 id=\"h-product-launch-overview\" class=\"wp-block-heading\">Product Launch Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Platform<\/strong><\/td><td>AXELIOS 1 single-molecule sequencing system<\/td><\/tr><tr><td><strong>Core Technology<\/strong><\/td><td>Proprietary Sequencing by Expansion (SBX)<\/td><\/tr><tr><td><strong>Key Advantages<\/strong><\/td><td>Accuracy, speed, flexibility, scalability, cost efficiency<\/td><\/tr><tr><td><strong>Performance Benchmark<\/strong><\/td><td>Same-day whole-genome sequencing capability<\/td><\/tr><tr><td><strong>Workflow Flexibility<\/strong><\/td><td>Seamless transition between small batches and large projects without system changes<\/td><\/tr><tr><td><strong>Strategic Positioning<\/strong><\/td><td>Potential replacement for existing sequencing technologies in pivotal research areas<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-technology-profile-sequencing-by-expansion-sbx\" class=\"wp-block-heading\">Technology Profile: Sequencing by Expansion (SBX)<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Innovation<\/strong>: First commercial platform utilizing Roche&#8217;s proprietary SBX technology<\/li>\n\n\n\n<li><strong>Architecture<\/strong>: Single-molecule sequencing with real-time data generation<\/li>\n\n\n\n<li><strong>Speed Advantage<\/strong>: Capable of producing whole-genome results within 24 hours<\/li>\n\n\n\n<li><strong>Scalability<\/strong>: Adaptable workflow supports both targeted panels and comprehensive genomic analyses<\/li>\n\n\n\n<li><strong>Operational Efficiency<\/strong>: Eliminates need for multiple instrument platforms or complex workflow transitions<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">AXELIOS 1 represents a paradigm shift in genomic sequencing by combining the accuracy of long-read technologies with the throughput and cost-efficiency traditionally associated with short-read platforms. The SBX technology fundamentally addresses the trade-offs that have historically plagued genomic research\u2014where researchers had to choose between speed, accuracy, cost, or scalability.<\/p>\n\n\n\n<h2 id=\"h-market-impact-amp-research-applications\" class=\"wp-block-heading\">Market Impact &amp; Research Applications<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Application Area<\/th><th>Strategic Value<\/th><\/tr><\/thead><tbody><tr><td><strong>Disease Research<\/strong><\/td><td>Enables rapid discovery of genetic variants and disease mechanisms<\/td><\/tr><tr><td><strong>Clinical Genomics<\/strong><\/td><td>Potential to accelerate diagnostic timelines and therapeutic decision-making<\/td><\/tr><tr><td><strong>Pharmaceutical Development<\/strong><\/td><td>Supports target identification and biomarker discovery with unprecedented speed<\/td><\/tr><tr><td><strong>Academic Research<\/strong><\/td><td>Democratizes access to high-performance sequencing through operational simplicity<\/td><\/tr><tr><td><strong>Competitive Disruption<\/strong><\/td><td>Positioned to replace existing technologies in high-value research segments<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The global genomics market, valued at approximately $25 billion in 2026, continues to face significant barriers related to sequencing speed, cost, and workflow complexity. AXELIOS 1 directly addresses these challenges by offering a unified platform that can handle diverse project requirements\u2014from rapid targeted sequencing to comprehensive whole-genome analysis\u2014without requiring researchers to invest in multiple specialized instruments or develop separate workflows.<\/p>\n\n\n\n<h2 id=\"h-strategic-implications-for-roche\" class=\"wp-block-heading\">Strategic Implications for Roche<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Technology Leadership<\/strong>: Establishes Roche as an innovator in next-generation sequencing beyond its traditional diagnostics stronghold<\/li>\n\n\n\n<li><strong>Market Expansion<\/strong>: Opens new revenue streams in research tools and life sciences markets<\/li>\n\n\n\n<li><strong>Integrated Portfolio<\/strong>: Complements Roche&#8217;s existing molecular diagnostics and pharmaceutical development capabilities<\/li>\n\n\n\n<li><strong>Competitive Differentiation<\/strong>: Proprietary SBX technology creates sustainable intellectual property moat<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The platform&#8217;s ability to deliver same-day whole-genome results could fundamentally alter research timelines and clinical workflows, potentially accelerating drug discovery cycles and enabling real-time genomic decision support in clinical settings.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding product performance, market adoption, and competitive positioning of AXELIOS 1. Actual results may differ due to risks including technological implementation challenges, competitive responses, and market acceptance rates.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY) announced the commercial launch of AXELIOS 1, its&#8230;<\/p>\n","protected":false},"author":1,"featured_media":69083,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,22],"tags":[40,940,163,939],"class_list":["post-69082","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-medical-device","tag-market-launch","tag-otcmkts-rhhby","tag-roche","tag-swx-rop"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Roche Launches AXELIOS 1 Next-Generation Sequencing Platform Powered by Proprietary SBX Technology \u2013 Single-Molecule System Promises Same-Day Whole Genome Results - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY) announced the commercial launch of AXELIOS 1, its next-generation single-molecule sequencing platform powered by proprietary sequencing by expansion (SBX) technology, designed to address critical bottlenecks in genomics research and clinical applications.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=69082\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Roche Launches AXELIOS 1 Next-Generation Sequencing Platform Powered by Proprietary SBX Technology \u2013 Single-Molecule System Promises Same-Day Whole Genome Results\" \/>\n<meta property=\"og:description\" content=\"Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY) announced the commercial launch of AXELIOS 1, its next-generation single-molecule sequencing platform powered by proprietary sequencing by expansion (SBX) technology, designed to address critical bottlenecks in genomics research and clinical applications.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=69082\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-30T03:57:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-30T03:58:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/3003.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69082#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69082\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Roche Launches AXELIOS 1 Next-Generation Sequencing Platform Powered by Proprietary SBX Technology \u2013 Single-Molecule System Promises Same-Day Whole Genome Results\",\"datePublished\":\"2026-06-30T03:57:59+00:00\",\"dateModified\":\"2026-06-30T03:58:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69082\"},\"wordCount\":459,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69082#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/3003.webp\",\"keywords\":[\"Market launch\",\"OTCMKTS: RHHBY\",\"Roche\",\"SWX: ROP\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=69082#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69082\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=69082\",\"name\":\"Roche Launches AXELIOS 1 Next-Generation Sequencing Platform Powered by Proprietary SBX Technology \u2013 Single-Molecule System Promises Same-Day Whole Genome Results - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69082#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69082#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/3003.webp\",\"datePublished\":\"2026-06-30T03:57:59+00:00\",\"dateModified\":\"2026-06-30T03:58:00+00:00\",\"description\":\"Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY) announced the commercial launch of AXELIOS 1, its next-generation single-molecule sequencing platform powered by proprietary sequencing by expansion (SBX) technology, designed to address critical bottlenecks in genomics research and clinical applications.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69082#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=69082\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69082#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/3003.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/3003.webp\",\"width\":1080,\"height\":608,\"caption\":\"Roche Launches AXELIOS 1 Next-Generation Sequencing Platform Powered by Proprietary SBX Technology \u2013 Single-Molecule System Promises Same-Day Whole Genome Results\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69082#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Roche Launches AXELIOS 1 Next-Generation Sequencing Platform Powered by Proprietary SBX Technology \u2013 Single-Molecule System Promises Same-Day Whole Genome Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Roche Launches AXELIOS 1 Next-Generation Sequencing Platform Powered by Proprietary SBX Technology \u2013 Single-Molecule System Promises Same-Day Whole Genome Results - Insight, China&#039;s Pharmaceutical Industry","description":"Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY) announced the commercial launch of AXELIOS 1, its next-generation single-molecule sequencing platform powered by proprietary sequencing by expansion (SBX) technology, designed to address critical bottlenecks in genomics research and clinical applications.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=69082","og_locale":"en_US","og_type":"article","og_title":"Roche Launches AXELIOS 1 Next-Generation Sequencing Platform Powered by Proprietary SBX Technology \u2013 Single-Molecule System Promises Same-Day Whole Genome Results","og_description":"Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY) announced the commercial launch of AXELIOS 1, its next-generation single-molecule sequencing platform powered by proprietary sequencing by expansion (SBX) technology, designed to address critical bottlenecks in genomics research and clinical applications.","og_url":"https:\/\/flcube.com\/?p=69082","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-06-30T03:57:59+00:00","article_modified_time":"2026-06-30T03:58:00+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/3003.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=69082#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=69082"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Roche Launches AXELIOS 1 Next-Generation Sequencing Platform Powered by Proprietary SBX Technology \u2013 Single-Molecule System Promises Same-Day Whole Genome Results","datePublished":"2026-06-30T03:57:59+00:00","dateModified":"2026-06-30T03:58:00+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=69082"},"wordCount":459,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=69082#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/3003.webp","keywords":["Market launch","OTCMKTS: RHHBY","Roche","SWX: ROP"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=69082#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=69082","url":"https:\/\/flcube.com\/?p=69082","name":"Roche Launches AXELIOS 1 Next-Generation Sequencing Platform Powered by Proprietary SBX Technology \u2013 Single-Molecule System Promises Same-Day Whole Genome Results - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=69082#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=69082#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/3003.webp","datePublished":"2026-06-30T03:57:59+00:00","dateModified":"2026-06-30T03:58:00+00:00","description":"Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY) announced the commercial launch of AXELIOS 1, its next-generation single-molecule sequencing platform powered by proprietary sequencing by expansion (SBX) technology, designed to address critical bottlenecks in genomics research and clinical applications.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=69082#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=69082"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=69082#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/3003.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/3003.webp","width":1080,"height":608,"caption":"Roche Launches AXELIOS 1 Next-Generation Sequencing Platform Powered by Proprietary SBX Technology \u2013 Single-Molecule System Promises Same-Day Whole Genome Results"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=69082#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Roche Launches AXELIOS 1 Next-Generation Sequencing Platform Powered by Proprietary SBX Technology \u2013 Single-Molecule System Promises Same-Day Whole Genome Results"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/3003.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/69082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=69082"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/69082\/revisions"}],"predecessor-version":[{"id":69084,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/69082\/revisions\/69084"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/69083"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=69082"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=69082"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=69082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}